HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leena Bruckner-Tuderman Selected Research

Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)

11/2016Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.
3/2014The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome.
1/2013Laminin 332 in junctional epidermolysis bullosa.
12/2005Molecular mechanisms of junctional epidermolysis bullosa: Col 15 domain mutations decrease the thermal stability of collagen XVII.
1/2005Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.
6/2004Keratinocytes from patients lacking collagen XVII display a migratory phenotype.
1/2004Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.
12/2002Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literature.
1/2002Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leena Bruckner-Tuderman Research Topics

Disease

26Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2022 - 01/2002
20Bullous Pemphigoid (Pemphigoid)
05/2015 - 03/2003
12Neoplasms (Cancer)
01/2021 - 07/2003
11Epidermolysis Bullosa
06/2019 - 12/2002
10Fibrosis (Cirrhosis)
01/2022 - 04/2011
10Inflammation (Inflammations)
06/2019 - 09/2009
9Wounds and Injuries (Trauma)
11/2020 - 01/2002
9Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
11/2016 - 01/2002
8Skin Diseases (Skin Disease)
01/2017 - 04/2005
6Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
06/2019 - 01/2002
6Pemphigus (Pemphigus Vulgaris)
01/2019 - 05/2008
6Blister (Bulla)
11/2014 - 12/2006
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 07/2003
4Poikiloderma of Kindler
12/2016 - 01/2004
4Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
04/2012 - 06/2003
3Disease Progression
01/2019 - 01/2005
3Carcinoma (Carcinomatosis)
03/2015 - 07/2003
2Cicatrix (Scar)
01/2022 - 01/2002
2Congenital Abnormalities (Deformity)
01/2019 - 05/2008
2Carcinogenesis
02/2016 - 07/2003
2Eosinophilia
05/2015 - 05/2007
2Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
03/2015 - 05/2011
2Inborn Genetic Diseases (Disease, Hereditary)
07/2014 - 10/2012
2Linear IgA Bullous Dermatosis
03/2014 - 07/2009
2Atrophy
11/2011 - 10/2009
2Leg Ulcer
09/2010 - 07/2006
2Muscular Dystrophies (Muscular Dystrophy)
03/2010 - 04/2004
2Atopic Dermatitis (Atopic Eczema)
07/2008 - 04/2005
2Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
05/2008 - 04/2006
2Hypereosinophilic Syndrome (Loeffler Endocarditis)
05/2007 - 01/2006
1Foot Deformities (Foot Deformity)
01/2019
1Wound Infection (Wound Infections)
01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Pityriasis Rubra Pilaris
11/2016
1Papilloma (Papillomatosis)
02/2016

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2002
20Collagen Type XVIIIBA
01/2018 - 01/2002
19CollagenIBA
01/2022 - 01/2002
17AutoantibodiesIBA
01/2019 - 03/2003
12Collagen Type VIIIBA
01/2019 - 06/2003
6IntegrinsIBA
01/2021 - 11/2011
6AntigensIBA
03/2012 - 12/2002
5Keratins (Keratin)IBA
06/2019 - 01/2002
5AntibodiesIBA
01/2012 - 12/2002
5AutoantigensIBA
10/2010 - 01/2008
4ProteomeIBA
10/2021 - 09/2010
4Messenger RNA (mRNA)IBA
01/2018 - 11/2004
4EpitopesIBA
05/2015 - 03/2003
4Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2013 - 01/2002
3DapsoneFDA Link
01/2019 - 03/2009
3Immunoglobulin G (IgG)IBA
01/2019 - 05/2011
3Immunoglobulin E (IgE)IBA
05/2015 - 05/2011
3Ointments (Pastes)IBA
03/2014 - 04/2005
3KalininIBA
01/2013 - 01/2002
3CytokinesIBA
04/2011 - 05/2009
3Tacrolimus (Prograf)FDA LinkGeneric
01/2010 - 04/2005
2Desmoglein 3IBA
01/2019 - 01/2010
2Rituximab (Mabthera)FDA Link
01/2019 - 05/2008
2SteroidsIBA
01/2019 - 03/2014
2Biological ProductsIBA
01/2018 - 10/2009
2Complement System Proteins (Complement)IBA
12/2017 - 03/2012
2Nonsense Codon (Nonsense Mutation)IBA
01/2017 - 01/2004
2Desmoplakins (Desmoplakin)IBA
03/2015 - 10/2012
2Laminin (Merosin)IBA
03/2015 - 11/2004
2Immunoglobulin A (IgA)IBA
03/2014 - 05/2011
2LigandsIBA
06/2012 - 04/2006
2Peptides (Polypeptides)IBA
02/2011 - 10/2010
2PlectinIBA
03/2010 - 04/2004
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2010 - 03/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2010 - 03/2009
2Azathioprine (Imuran)FDA LinkGeneric
01/2010 - 03/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2009 - 07/2008
2Imatinib Mesylate (Gleevec)FDA Link
05/2007 - 01/2006
2ProcollagenIBA
09/2002 - 07/2002
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1Thrombospondin 1IBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1Protein AggregatesIBA
06/2019
14-phenylbutyric acid (Buphenyl)FDA Link
06/2019
1Keratin-5 (Keratin 5)IBA
06/2019
1DecorinIBA
01/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1APOBEC DeaminasesIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2018
1amlexanox (Aphthasol)FDA Link
01/2017
1AntioxidantsIBA
12/2016
1secukinumabIBA
11/2016
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
02/2016
1CarcinogensIBA
02/2016
1Sirolimus (Rapamycin)FDA Link
01/2016
1Interleukin-6 (Interleukin 6)IBA
09/2015
1Losartan (Cozaar)FDA LinkGeneric
09/2015

Therapy/Procedure

19Therapeutics
01/2022 - 09/2002
2Injections
01/2022 - 01/2009
2Intradermal Injections
11/2014 - 09/2009
2Cell- and Tissue-Based Therapy (Cell Therapy)
11/2014 - 09/2009
1Radiotherapy
01/2019
1Precision Medicine
01/2017
1Palliative Care (Palliative Therapy)
11/2016